fresh US Food and Drug Administrati...

fresh US Food and Drug Administration (FDA) regulations will streamline the proces for making safe, effective generic medications available to consumer according to a June 12 2003 recents release from the FDA. Medication manufacturers now will be limited to simply a 30-month delay of a generic medication's inlet into the market for resolution of a patent challenge. These regulation changes are rely uponed to save consumers an estimated $35 billion during the nearest 10 years by making les sumptuous generic alternatives to brand-name medications available more quickly.

Changes in the FDA's review proces will be made to improve the spe and bring to the cost of determining that a of recent origin generic medication is safe and effective. The FDA also plans to expand its educational programs and partnerships to help consumer prepare accurate information about the availability of generic medications for their health necessitys and to ensure that consumer are aware that FDA-approved generic medications are as safe and effective as their brand-name equivalents.

HH Revises Regulations and measures to Speed Access to Generic medicines (news release, Rockville, Md: US nutrition and Drug Administration, June 12 2003)

COPYRIGHT 2003 Association of Operating sweep Nurses, Inc.

COPYRIGHT 2003 Gale Group